# Beta Blocker Interruption After Uncomplicated Myocardial Infarction

> **NCT03498066** · PHASE4 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 3700 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Beta-blockers withdrawal
- **DRUG:** Continuation of the Betablockers (βB) treatment

## Key facts

- **NCT ID:** NCT03498066
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-29
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 3700 (ACTUAL)
- **Last updated:** 2023-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03498066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03498066, "Beta Blocker Interruption After Uncomplicated Myocardial Infarction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03498066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*